LIGAND PHARMACEUTICALS INC (LGND) insider trading

By person

10 insiders · 154 transactions

88.2×

Todd C. Davis holds 88.2 times base salary in stock. $63.93M of shares against $724.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Todd C. Davis last reported holding, valued at $320.43, the price Common Stock was last bought or sold at on the open market here, on 2 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Octavio Espinoza

Chief Financial Officer

—

$13.03M (14) scheduled

−$13.03M

27,696

0.1389%

$8.87M

+5.0%

Andrew Reardon

CLO & Secretary

—

$11.86M (73) scheduled

−$11.86M

31,854

0.1598%

$10.21M

+47.1%

Jason Haas

Director

—

$3.74M (3) scheduled

−$3.74M

3,981

0.0200%

$1.28M

−26.2%

John L Lamattina

Director

—

$2.44M (7) scheduled

−$2.44M

26,969

0.1353%

$8.64M

−8.6%

Jason Aryeh

Director

—

$1.93M (8)

−$1.93M

116,758

0.5857%

$37.41M

−10.0%

Nancy Ryan Gray

Director

—

$1.35M (2) scheduled

−$1.35M

8,930

0.0448%

$2.86M

+29.7%

Stephen L Sabba

Director

—

$1.16M (3) scheduled

−$1.16M

33,629

0.1687%

$10.78M

+11.4%

John W Kozarich

Director

—

$1.02M (35) scheduled

−$1.02M

42,622

0.2138%

$13.66M

−2.6%

Martine Zimmermann

Director

—

$342.00K (1)

−$342.00K

3,782

0.0190%

$1.21M

+6.9%

Todd C Davis

Chief Executive Officer

—

199,513

1.00%

$63.93M

+62.2%

LIGAND PHARMACEUTICALS INC

What the insiders did Net selling

By person